Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zero-Hep: Heparin-free ECMO Support During Lung Transplantation
2024-519503-10-00Phase 4Completed
- Sponsor
- Medical University of Vienna
- Start
- Jan 2025
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of heparin in lung transplantation (2 arms), sponsored by Medical University of Vienna. Primary endpoints: Arterial or venous thromboembolic events and Circuit-related thrombosis. Started Jan 2025; status: completed.
02
Drugs
heparin
03
Conditions
lung transplantation
Beyond the preview
Go deeper on 2024-519503-10-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-519503-10-00.